Indeed, the role of FOXA1/AR co-expression in ER+ BC has not been investigated, although it has been suggested that the relative ratio among FOXA1, ER and AR could influence growth and aggressiveness of cancer cells [20]. The gene discussed is FOXA1; the disease is breast cancer.